Abstract:Brain metastatic carcinoma is a rare occurrence among prostate cancer metastases. 68Gallium prostate-specific membrane antigen PET-CT ([68Ga]PSMA PET/CT) is commonly used for prostate cancer staging and detection of biochemical recurrences. However, various CNS tumors exhibit activity on [68Ga]PSMA PET/CT and may often be included in the differential diagnosis. Herein, we present a case of brain metastatic prostate cancer successfully treated with surgical resection and adjuvant stereotactic Gamma Knife radiosurgery (GKRS) followed by androgen deprivation therapy (ADT) to emphasize the need for histologic confirmation. A 70-year-old male with a history of very high-risk prostatic adenocarcinoma presented with biochemical recurrence following radical prostatectomy and irradiation of the prostatic fossa. [68Ga]PSMA PET/CT and MRI identified a solitary lesion in the left occipital lobe; differential diagnosis included prostate metastasis, meningioma, or a new metastatic primary lesion. The patient underwent surgical resection, and immunohistochemical staining confirmed the lesion as brain metastatic prostate adenocarcinoma. One month after resection, the patient underwent GKRS to the tumor bed and two additional metastases, followed by ADT. Repeated imaging 15 months after GKRS revealed stable posttreatment changes with no evidence of new metastases, thus demonstrating durable, effective local and systemic control. Brain metastatic prostate adenocarcinoma without nodal or osseous metastases is a rare phenomenon. The affinity of [68Ga]PSMA PET/CT for non-prostate histologies such as meningioma introduces uncertainty into the diagnostic process. This case demonstrates the durable local control conferred by GKRS toward these lesions and emphasizes the need for clinical, radiographic, and histopathologic data to identify disease presentations and facilitate appropriate treatment regimens.

Late Subacute Cerebral Hematoma Mimicking a Metastasis on PSMA PET/CT

Prostate-Specific Membrane Antigen–Avid Neurofibroma Mimicking Cutaneous Metastasis in Metastatic Castration-Resistant Prostate Cancer on 18F-PSMA-1007 PET/CT

Glioblastoma Mimicking a Cerebral Contusion: A Case Report

Brain Metastatic Prostate Adenocarcinoma: Avoiding Mistaken Identities

Cerebral and Muscular Metastases From Prostate Adenocarcinoma Initially Depicted by 177Lu-PSMA SPECT/CT

Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT

Cerebrovascular Malformation Mimicking Recurrent Lymphoma on Dual Time-Point 18F-FDOPA PET

Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain

Hemangioma of the Ilium Simulating Bone Metastasis on 18F-PSMA-1007 PET/CT

Focal FDG Uptake in the Cerebral Parenchyma Beneath the Subdural Hematoma

PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer

Brain and Adrenal Metastasis From Unknown Primary Tumor: A Case Report

PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration

Late Pseudoprogression

Exophthalmos as the initial presentation of metastatic prostate cancer

Asymptomatic Prostate Cancer Metastasis in Rectal Mucosa Revealed by 18 F-PSMA-1007 PET/CT

Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma

Intra-Parenchymal Cerebellar Metastasis-A Rare Presentation of Castration-Resistant Prostate Cancer

Intense 18F-PSMA-1007 Uptake of Splenic Hemangioma

Incidental Prostate-Specific Membrane Antigen–Avid Vestibular Schwannoma Detected on 68Ga–Prostate-Specific Membrane Antigen PET/CT

68Ga-PSMA-11 PET Identified Tumor Recurrence in Prostatectomy Bed With Rising PSA of 0.9 ng/mL but Negative on MRI and 18F-Fluciclovine PET Scan